Internal tandem duplication of the flt3 gene found in acute myeloid leukemia

Leukemia

Volumn 10, Issue 12, 1996, Pages 1911-1918

  Nakao, M ^a   Yokota, S ^a   Iwai, T ^a   Kaneko, H ^a   Horiike, S ^a   Kashima, K ^a   Sonoda, Y ^a   Fujimoto, T ^b   Misawa, S ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute leukemia; flt3; Mutation; RT PCR

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE KINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; EXON; GENE DUPLICATION; HUMAN; HUMAN CELL; INTRON; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TANDEM REPEAT;

EID: 0030451722     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Nicola NA. Hematopoietic cell growth factors and their receptors. Annu Rev Biochem 1989; 58: 45-77.
2. Lowenberg B, Touw I. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281-292.
3. Matthews W, Jordan CT, Wiegand CW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and pro-genitor cell-enriched populations. Cell 1991; 65: 1143-1152.
4. Rosnet O, Mattei MG, Marchetto S, Birnbaum D. Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics 1991; 9: 380-385.
5. + human bone marrow cells and is involved in the proliferation of early progenitor stem cells. Proc Natl Acad Sci USA 1993; 91: 459-463.
6. Lyman SD, Mames L, Zappone J, Sleath PR, Beckmann MP, Bird T. Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene. Oncogene 1993; 8: 815-822.
7. Rosnet O, Schiff C, Pebusque M-J, Marchetto S, Tonnelle C, Toiron Y, Birg F, Birnbaum D. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 1993; 82: 1110-1119.
8. Agnes F, Shamoon B, Dina C, Rosnet O, Birnbaum D, Galibert F. Genomic structure of the downstream part of the human FLT3 gene: exon/intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III. Gene 1994; 145: 283-288.
9. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203-212.
10. Lyman SD, James L, Vanden Bos T, De Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FA, Maraskovsky E, Farrah T, Foxworthe D, Williams DE, Beckmann MP. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993; 75: 1157-1167.
11. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda C, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Keiner G, Namikawa R, Rennick D, Lee F. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 1994; 368: 643-648.
12. Meierhoff G, Dehmel U, Gruss H-J, Rosnet O, Birnbaum D, Quentmeier H, Dirks W, Drexler HG. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 1995; 9: 1368-1372.
13. Birg F, Courcoul M, Rosnet O, Bardin F, Pebusque M-J, Marchetto S, Tabilio A, Mannoni P, Birnbaum D. Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 1992; 80: 2584-2593.
14. Da Silva N, Hu ZB, Ma W, Rosnet O, Birnbaum D, Drexler HG. Expression of the FLT3 gene in human leukemia-lymphoma cell lines. Leukemia 1994; 8: 885-888.
15. Brasel K, Escobar S, Anderberg R, de Vries P, Gruss H-J, Lyman SD. Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 1995; 9: 1212-1218.
16. Drexler HG. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia 1996; 10: 588-599.
17. Nakao M, Yokota S, Kaneko H, Seriu T, Koizumi S, Takaue Y, Fujimoto T, Misawa S. Alterations of CDKN2 gene structure in childhood acute lymphoblastic leukemia: mutations of CDKN2 are observed preferentially in T lineage. Leukemia 1996; 10: 249-254.
18. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. The morphological classification of acute lymphoblastic leukemia; concordance among observers and clinical correlations. Br J Haematol 1981; 47: 553-561.
19. Nakao M, Yokota S, Horiike S, Taniwaki M, Kashima K, Sonoda Y, Koizumi S, Takaue Y, Matsushita T, Fujimoto T, Misawa S. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia 1996; 10: 1463-1470.
20. Yokota S, Hansen-Hagge TE, Ludwig WD, Reiter A, Raghavachar A, Kleihauer E, Bartram CR. Use of polymerase chain reaction to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 1991; 77: 331-339.
21. Horiike S, Misawa S, Kaneko H, Nakai H, Ueda Y, Nakao M, Hirakawa K, Taniwaki M, Kashima K. Double mutations of N-ras gene in a patient with acute myelomonocytic leukemia. Int J Hematol 1995; 61: 205-213.
22. Tsujimura T, Furitsu T, Morimoto M, Isozaki K, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 1994; 83: 2619-2626.
23. Nakata Y, Kimura A, Katoh O, Kawaishi K, Hyodo H, Abe K, Kuramoto A, Satow Y. c-kit point mutation of extracellular domain in patients with myeloproliferative disorders. Br J Haematol 1995; 91: 661-663.
24. Tobal K, Pagliuca A, Bhatt B, Bailey N, Layton DM, Mufti GJ. Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 1990; 4: 486-489.
25. Schichman SA, Caligiuri MA, Gu Y, Strout MP, Canaani E, Bloomfield CD, Croce CM. ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA 1994; 91: 6236-6239.
26. Yu M, Honoki K, Andersen J, Paietta E, Nam DK, Yunis JJ. MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia 1996; 10: 774-780.
27. Coulier F, Kumar R, Ernst M, Klein R, Martin-Zanca D, Barbacid M. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain. Mol Cell Biol 1990; 10: 4202-4210.
28. Chia W, Savakis C, Karp R, Pelham H, Ashburner M. Mutation of the Adh gene of Drosophila melanogaster containing an internal tandem duplication. J Mol Biol 1985; 186: 679-688.
29. Piacibello W, Fubini L, Sanavio F, Brizzi MF, Severino A, Garetto L, Stacchini A, Pegoraro L, Aglietta M. Effects of human FLT3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors. Blood 1995; 86: 4105-4114.
30. Lisovsky M, Estrov Z, Consoli U, Munker R, Andreeff M. FLT3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia blasts. Blood 1995; 86: 22a.
31. McKenna HJ, Smith FO, Brasel K, Hirschstein D, Bernstein ID, Williams DE, Lyman SD. Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children. Exp Hematol 1996; 24: 378-385.
32. Dehmel U, Zaborski M, Meierhoff C, Rosnet O, Birnbaum D, Ludwig WD, Quentmeier H, Drexler HG. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells. Leukemia 1996; 10: 261-270.